Fig. 5From: Pan-cancer analysis identified IGF2BP2 as a potential prognostic biomarker for multiple tumor typesCorrelation between IGF2BP2 expression and cancer-associated fibroblast immune infiltration. EPIC, MCPCOUNTER, XCELL, and TIDE algorithms were used to calculate the correlation between IGF2BP2 expression and cancer-associated fibroblast immune infiltration in all tumor types from TCGABack to article page